Betacilin Clav Drops
(Amoxicillin and Clavulanate Potassium
for Oral Suspension) 62.5mg/mL, 15mL
Vetone CRO23011

Betacilin Clav Drops <br>(Amoxicillin and Clavulanate Potassium<br> for Oral Suspension) 62.5mg/mL, 15mL<br> Vetone CRO23011
Betacilin Clav Drops
(Amoxicillin and Clavulanate Potassium
for Oral Suspension) 62.5mg/mL, 15mL
Vetone CRO23011
Item# Vetone-CRO23011
Regular price: $20.00
Sale price: $16.99
Strength:  Size: 

Product Description

Betacilin Clav Drops <br>(Amoxicillin and Clavulanate Potassium<br> for Oral Suspension) 62.5mg/mL, 15mL<br> Vetone CRO23011
Betacilin Clav Drops
(Amoxicillin and Clavulanate Potassium
for Oral Suspension) 62.5mg/mL, 15mL
Vetone CRO23011

This item could be sold only to specialists with vali license and is not returnable .

Active Ingredient amoxicillin trihydrate | clavulanate potassium Description Betacilin Clav Drops are indicated in the treatment of:

Dogs: Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., and E. coli.

This item could be sold only to specialists with valid license and is not returnable .

Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Betacillin have been shown to be clinically effective for treating cases of canine periodontal disease.

Cats: Skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp.

Urinary tract infections (cystitis) due to susceptible strains of E. coli.

Therapy may be initiated with Betacillin prior to obtaining results from bacteriological and susceptibility studies. A culture should be obtained prior to treatment to determine susceptibility of the organisms to Betacillin. Following determination of susceptibility results and clinical response to medication, therapy may be reevaluated.